Irish Medicines Board proposes revised fee structure for 2010
This article was originally published in SRA
The Irish Medicines Board has proposed a revised fee structure for the financial year 2010 that takes into account the new European Union regulation on variations (Regulation EC 1234/2008), which comes into force on 1 January1,2.
You may also be interested in...
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.